Amanote Research
Register
Sign In
Second US Institute Investigates Use of Drug in Asthma Trial
BMJ
doi 10.1136/bmj.323.7308.299/a
Full Text
Open PDF
Abstract
Available in
full text
Date
August 11, 2001
Authors
D. Josefson
Publisher
BMJ
Related search
Reinventing the US Institute of Medicine: A Second Coming
American Journal of Medicine
Medicine
Self-Management Research of Asthma and Good Drug Use (SMARAGD Study): A Pilot Trial
International Journal of Clinical Pharmacy
Toxicology
Pharmacy
Pharmacology
Pharmaceutical Science
When Networks Can Teach Us About Drug Use
British Medical Journal
Medicine
US Medical Institute Invests in Undergraduates
Nature
Multidisciplinary
Changing Patterns of Asthma Medication Use Related to US Food and Drug Administration Long-Acting Β2-Agonist Regulation From 2005-2011
Journal of Allergy and Clinical Immunology
Allergy
Immunology
A Randomized Trial Testing US Food and Drug Administration “Breakthrough” Language
JAMA Internal Medicine
Internal Medicine
Biological Drug Use: US Perspectives on Indications and Monitoring
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Racial Discrimination, Socioeconomic Position, and Illicit Drug Use Among US Blacks
Social Psychiatry and Psychiatric Epidemiology
Psychiatry
Epidemiology
Mental Health
Health
Social Psychology
The Impact of the US Food and Drug Administration Chlorofluorocarbon Ban on Out-Of-Pocket Costs and Use of Albuterol Inhalers Among Individuals With Asthma
JAMA Internal Medicine
Internal Medicine
